Skip to main content
Premium Trial:

Request an Annual Quote

GWU Taps Internet2's Infrastructure to Handle Data Transfer

Premium

Researchers at George Washington University's Colonial One High Performance Computing Center will use Internet2's 100 gigabit network technology to move large biomedical datasets from National Institutes of Health's National Library of Medicine, the university said last week.

Improved access to data "will enable us to provide our genomic clients with faster results, ultimately hastening discovery and therapeutic decisions," according to Raja Mazumder, associate professor of biochemistry and molecular medicine at the GW School of Medicine and Health Sciences. He is also the co-developer of the High-performance Integrated Virtual Environment, a genomic analysis platform used at GWU.

Commenting on Internet2's selection by GWU, Michael Sullivan, associate director of the nonprofit organization, said that the 100 gigabit network will enable HIVE "realize its full potential by removing external bottlenecks."

Filed under

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.